Stay updated on Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Sign up to get notified when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.

Latest updates to the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page
- Check4 days agoChange DetectedThe page now displays the completed Phase 2 KZR-616 study record, including its eligibility criteria, treatment arms, outcome measures, locations, and study dates.SummaryDifference65%

- Check11 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA banner announces NIH website transition updates, including the change in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study record page is now a 403 Forbidden page, replacing the detailed trial information with a generic error screen and removing the locations, eligibility criteria, and other key details.SummaryDifference20%

- Check59 days agoChange DetectedPage revision tag updated from v3.6.6 to v3.7.0.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.